Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 2,503 | 1,748 | 2,241 | 2,895 | 2,383 |
| Operating Income | -2,503 | -1,748 | -2,241 | -2,895 | -2,383 |
| Other Income | 111 | 119 | 116 | 104 | 64 |
| Pre-tax Income | -2,392 | -1,628 | -2,125 | -2,791 | -2,319 |
| Net Income Continuous | -2,392 | -1,628 | -2,125 | -2,791 | -2,319 |
| Net Income | $-2,392 | $-1,628 | $-2,125 | $-2,791 | $-2,319 |
| EPS Basic Total Ops | -0.19 | -0.13 | -0.17 | -0.22 | -0.18 |
| EPS Basic Continuous Ops | -0.19 | -0.13 | -0.17 | -0.22 | -0.18 |
| EPS Diluted Total Ops | -0.19 | -0.13 | -0.17 | -0.22 | -0.18 |
| EPS Diluted Continuous Ops | -0.19 | -0.13 | -0.17 | -0.22 | -0.18 |
| EBITDA(a) | $-2,502 | $-1,747 | $-2,240 | $-2,894 | $-2,382 |